Potentiating T cell tumor targeting using a combination of TCR with a Siglec-7 based CSR
Shiran Didi-Zurinam(Bar-Ilan University), Cyrille J. Cohen(Bar-Ilan University)
Cited by 0
Related Papers
A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
|Journal for ImmunoTherapy of Cancer|2019|79